Dean Irwin Sells 21,982 Shares of RA Medical Systems Inc (RMED) Stock

RA Medical Systems Inc (NYSE:RMED) insider Dean Irwin sold 21,982 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $3.82, for a total transaction of $83,971.24. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Dean Irwin also recently made the following trade(s):

  • On Thursday, April 11th, Dean Irwin sold 20,928 shares of RA Medical Systems stock. The shares were sold at an average price of $3.49, for a total transaction of $73,038.72.

Shares of NYSE:RMED opened at $4.18 on Wednesday. The company has a quick ratio of 11.28, a current ratio of 11.64 and a debt-to-equity ratio of 0.01. RA Medical Systems Inc has a 12 month low of $3.34 and a 12 month high of $22.00. The stock has a market capitalization of $53.67 million and a P/E ratio of -1.25.

RA Medical Systems (NYSE:RMED) last announced its quarterly earnings results on Monday, May 13th. The company reported ($1.16) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.38) by ($0.78). The company had revenue of $1.75 million for the quarter, compared to analysts’ expectations of $1.22 million. On average, sell-side analysts forecast that RA Medical Systems Inc will post -1.93 earnings per share for the current year.

Several large investors have recently made changes to their positions in the stock. Millennium Management LLC lifted its holdings in shares of RA Medical Systems by 411.9% in the 4th quarter. Millennium Management LLC now owns 503,875 shares of the company’s stock valued at $4,006,000 after acquiring an additional 405,443 shares during the last quarter. Orbimed Advisors LLC lifted its holdings in shares of RA Medical Systems by 16.7% in the 4th quarter. Orbimed Advisors LLC now owns 350,000 shares of the company’s stock valued at $2,783,000 after acquiring an additional 50,000 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of RA Medical Systems by 30.4% in the 4th quarter. Principal Financial Group Inc. now owns 305,392 shares of the company’s stock valued at $2,428,000 after acquiring an additional 71,237 shares during the last quarter. Neuberger Berman Group LLC lifted its holdings in shares of RA Medical Systems by 5.2% in the 1st quarter. Neuberger Berman Group LLC now owns 256,760 shares of the company’s stock valued at $873,000 after acquiring an additional 12,661 shares during the last quarter. Finally, Wasatch Advisors Inc. lifted its holdings in shares of RA Medical Systems by 16.6% in the 1st quarter. Wasatch Advisors Inc. now owns 239,944 shares of the company’s stock valued at $816,000 after acquiring an additional 34,124 shares during the last quarter. 31.93% of the stock is owned by hedge funds and other institutional investors.

Several research analysts have commented on the stock. Maxim Group dropped their price objective on shares of RA Medical Systems to $12.00 and set a “buy” rating for the company in a report on Wednesday. Zacks Investment Research raised shares of RA Medical Systems from a “sell” rating to a “hold” rating in a report on Tuesday. SunTrust Banks reissued a “positive” rating and set a $10.00 price objective on shares of RA Medical Systems in a report on Tuesday, March 26th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $11.00 price objective on shares of RA Medical Systems in a report on Tuesday, March 26th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $14.00.

WARNING: This news story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2019/05/15/dean-irwin-sells-21982-shares-of-ra-medical-systems-inc-rmed-stock.html.

RA Medical Systems Company Profile

Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.

Featured Article: Trading Stocks – What are percentage gainers?

Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.